The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.140
+0.070 (2.28%)
At close: Apr 1, 2026, 4:00 PM EDT
3.271
+0.131 (4.16%)
Pre-market: Apr 2, 2026, 4:32 AM EDT

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
CurrentQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Apr '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
310352341191101232535117151103415012141136452268228687
Market Cap Growth
206.14%1403.89%1278.60%450.67%-13.66%-84.53%-76.07%-15.34%134.84%25.12%-74.91%-88.74%-90.43%-82.27%43.94%320.89%548.81%629.75%275214.06%5.53%
Enterprise Value
380.54414.92409.25257.13157.1390.0993.5102.85165.03181.71127.08112.1799.01149.76421.68314.63441.33566.84515.57286.44
Last Close Price
3.143.563.492.051.140.310.330.461.582.041.400.550.681.654.635.067.139.759.949.95
PE Ratio
--6.36-5.45-3.01-1.63-0.44-0.42-0.58-1.95-2.22-1.61-0.65-0.94-9.17-30.87-168.6789.13-65.00-99.40-76.54
PS Ratio
0.620.700.740.450.250.060.070.100.340.470.330.140.180.481.761.652.493.361.430.59
PB Ratio
--22.39-27.74-21.2820.006.521.601.192.842.651.440.480.510.983.222.943.966.55-11.4817.31
P/TBV Ratio
-18.44-22.98-27.72-21.2617.346.511.601.182.842.631.440.480.511.152.882.984.116.55-26.35131.38
P/FCF Ratio
--12.67-12.37-14.63-5.29-0.77-0.66-0.72-2.93-3.70-1.98-0.64-0.75-1.80-4.91-5.53-8.47-15.55-24.30-10.55
P/OCF Ratio
--14.31-14.41-18.78-6.48-0.88-0.71-0.79-3.20-4.17-2.22-0.70-0.83-1.96-5.18-5.90-8.94-16.63-30.32-12.69
EV/Sales Ratio
0.760.830.890.610.390.230.250.280.480.560.410.380.360.591.811.432.112.792.581.94
EV/EBITDA Ratio
--14.24-12.01-6.42-3.46-1.67-1.63-1.80-2.95-2.55-1.56-1.27-1.08-1.93-4.48-4.11-7.40-13.15-255.48-314.93
EV/EBIT Ratio
--11.50-9.96-5.48-3.02-1.50-1.47-1.62-2.66-2.36-1.46-1.21-1.03-1.83-4.29-3.92-6.99-12.21-98.60-87.58
EV/FCF Ratio
--14.93-14.87-19.67-8.21-2.97-2.49-2.14-4.12-4.44-2.44-1.74-1.49-2.23-5.03-4.78-7.15-12.92-43.84-34.93
Debt / Equity Ratio
-6.14-6.14-7.85-10.7118.8432.427.513.922.751.991.551.301.060.830.790.120.11000
Debt / EBITDA Ratio
-3.56-19.66-16.36-10.97-12.59-12.05-10.01-8.15-7.27-8.73-9.60-8.55-3.48-4.53-5.59-1.11-1.070.00--
Debt / FCF Ratio
-3.7347.72-7.82-9.04-19.2450.66100.70-6.92-7.27-25.17-12.70-12.12-6.36-6.76-4.91-1.63-1.04-0.01--
Net Debt / Equity Ratio
-4.46-4.46-6.18-8.1112.3420.484.882.561.310.650.420.910.560.280.12-0.36-0.58-1.100.01-0.12
Net Debt / EBITDA Ratio
-2.41-13.29-11.99-7.75-7.70-7.19-6.15-5.03-3.28-2.68-2.45-5.67-1.73-1.44-0.822.624.392.840.161.93
Net Debt / FCF Ratio
-2.5232.27-5.73-6.39-11.7730.2361.87-4.27-3.27-7.74-3.24-8.04-3.16-2.15-0.723.854.273.530.060.08
Asset Turnover
0.840.840.800.710.570.530.500.480.430.360.330.380.350.310.250.290.250.390.230.22
Inventory Turnover
31.718.878.147.557.317.227.677.287.586.235.956.286.897.1110.3811.6011.038.15--
Quick Ratio
1.311.311.341.331.501.882.192.872.733.624.212.573.383.843.832.593.854.580.060.25
Current Ratio
1.591.591.681.621.792.152.493.313.084.124.713.113.954.394.373.114.445.170.08296.69
Return on Equity (ROE)
123.78%123.78%-1028.93%-168.23%-84.48%-43.49%-36.90%-27.17%-28.47%-20.82%-17.44%-16.19%-26.04%-9.68%-1.61%-3.31%11.22%-15.36%-1.39%1.49%
Return on Assets (ROA)
-4.09%-4.09%-4.70%-6.56%-5.38%-6.25%-6.97%-7.99%-8.18%-6.49%-5.59%-7.16%-14.92%-10.44%-7.75%-8.66%-8.36%-36.79%-1.28%-0.39%
Return on Invested Capital (ROIC)
-9.53%-9.53%-9.51%-12.62%-11.60%-13.59%-14.11%-12.22%-14.14%-11.69%-10.39%-11.69%-27.60%-21.84%-10.16%-11.32%-12.65%-104.11%-1.29%-0.39%
Return on Capital Employed (ROCE)
-6.45%-6.45%-6.99%-9.36%-7.53%-8.09%-8.70%-9.60%-9.89%-7.52%-6.37%-8.53%-17.32%-12.37%-8.42%-9.59%-9.10%-39.30%-0.94%-0.49%
Earnings Yield
-16.21%-15.73%-18.34%-33.17%-61.40%-229.77%-238.61%-171.74%-51.27%-45.10%-62.14%-154.49%-106.21%-10.91%-3.24%-0.59%1.12%-1.54%-1.01%-1.31%
FCF Yield
-8.95%-7.90%-8.08%-6.84%-18.89%-129.59%-151.87%-138.15%-34.14%-27.03%-50.49%-157.18%-133.19%-55.66%-20.38%-18.09%-11.81%-6.43%-4.12%-9.48%
Buyback Yield / Dilution
-23.11%-34.10%-29.06%-24.69%-3.86%-2.98%-2.46%-0.85%-1.07%14.16%7.38%-1.54%3.49%-22.36%-20.54%-10.56%-21.09%-18.24%-187.05%-187.05%
Total Shareholder Return
-23.11%-34.10%-29.06%-24.69%-3.86%-2.98%-2.46%-0.85%-1.07%14.16%7.38%-1.54%3.49%-22.36%-20.54%-10.56%-21.09%-18.24%-187.05%-187.05%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q